Netsuite founder Evan Goldberg hopes the lessons he’s learned from building a software company can help researchers find new ways to treat cancers.
When Netsuite founder Evan Goldberg was contacted by his birth mother it was not all good news, she revealed to him she had one of the BRAC genetic markers, an hereditary trait that indicates a high risk of breast cancer.
A day before the official launch of the BRAC Foundation he has founded with a ten million dollar donation, Goldberg spoke to Decoding the New Economy at the Suiteworld conference in San Jose about how he believes he can help improve the treatement of cancers.
“How I think I can make a difference is applying some of the things we’ve learned at Netsuite,” he explained. “Netsuite has been all about breaking down silos, it’s not a system to run a department, it’s to run a business.”
“Much research and money is focused on a particular type of cancer – breast cancer, lung cancer, prostate cancer but it turns out from what we’ve learned from genetic research that cancers can be more similar to each other across different cancer types than to those in the same organs.”
“So in the same way we’re trying to break down silos between parts of a business, trying to break down silos between researchers, different institutions has sort of been a theme of mine.”
“What’s really interesting this notion of looking at where the cancer started, which is what we’ve been doing for a hundred years, looking at what is the mechanism underneath it is kind of how we’ve looked at business at Netsuite.”
“We’re supporting research in the BRCA Foundation from numerous different institutions and researchers that are looking at all different types of cancer. So bringing them together and cutting through all sorts of silos, these sort of artificial silos – some of which still have value in some ways – but fostering collaboration where there wasn’t any before.”
“It’s not a perfect analogy,” Goldberg admits, “but I do think that this notion of looking at cancer across different dimensions is similar to how we’ve been looking at business.”
“It’s a totally different world, the world of medics, research institutions, hospitals and clinicians, it’s a very different world to the businesses I’m used to deal with. Although there are still similarities in the motivations and the barriers to success.”
One has to hope BRAC Foundation will be successful however Goldberg is the first to admit the bulk of the work lies with the scientists. “The real hard work is done by the researchers,” he says. “Hopefully we can help them.”